Osteopontin (OPN) is a secreted, multifunctional, extracellular matrix (ECM), calcium-binding, glycosylated phosphoprotein that is associated with various normal biological functions and pathological processes. OPN is physiologically produced by a wide range of cells and has been identified in various body fluids, playing a crucial role in bone remodeling and vascularization. OPN is also expressed by multiple immune cells, acting as a chemotactic factor, a mediator of cell activation and cytokine production, and an anti-apoptotic factor, thereby regulating inflammation and immune responses. OPN can be involved in the tumorigenesis of various cancer types, including head and neck squamous cell carcinoma (HNSCC), by promoting cell proliferation, adhesion, invasion, and migration through multiple signaling pathways[1][2].
Anti-Mouse osteopontin/SPP1 Antibody (100D3) 是一种抗小鼠 osteopontin/SPP1 的 IgG2c 单克隆抗体,可逆转骨桥蛋白 (OPN) 对 T 细胞的抑制作用并增强细胞毒性 T 淋巴细胞 (CTL) 的杀伤能力,还能提高牙本质密度,可用于研究癌症和牙齿相关疾病(如结肠癌),其同型对照为 Mouse IgG2c kappa, Isotype Control (MS-J64914)。
Anti-Mouse osteopontin/SPP1 Antibody (103D6) 是一种源自小鼠的抗小鼠 osteopontin/SPP1 IgG2c κ 型抗体抑制剂,可增强细胞毒性 T 淋巴细胞的裂解活性并抑制结肠肿瘤生长,还能改善胆总管结扎 (CBDL) 诱导的原发性硬化性胆管炎模型小鼠的肝损伤。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号